Financial Year |
March 31 2023 |
Monetary Funds |
1,711,056,227.26 |
Held-for-trading Financial Assets |
3,224,390,079.84 |
Notes Receivable |
-- |
Accounts Receivable |
473,589,632.17 |
Advances to Suppliers |
6,389,963.81 |
Other Receivables |
84,859,990.74 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
617,818,781.17 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,875,499.87 |
Total Current Assets |
6,239,082,168.98 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
729,272.86 |
Fixed Assetes |
630,854,314.35 |
Under-construction Projects |
77,451,318.86 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
308,349,181.70 |
R&D expenses |
41,582,919.57 |
Goodwill |
663,841,978.78 |
Long-Term Deferred and Prepaid Expenses |
43,320,083.49 |
Deferred Income Tax Assets |
38,351,757.00 |
Other Non-Current Assets |
20,662,082.80 |
Sub-Total of Non-Current Assets |
1,957,301,612.62 |
Total Assets |
8,196,383,781.60 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
40,375,813.78 |
Accounts Payable |
274,567,189.10 |
Accounts Received In Advance |
4,285.69 |
Employee Compensation Payable |
84,851,322.42 |
Taxes Payable |
53,984,795.27 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
260,452,257.94 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,820,624.37 |
Other Current Liabilities |
1,778,707.88 |
Sub-Total of Current Liabilities |
729,980,263.09 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
5,446,956.34 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
41,256,452.60 |
Total Liabilities |
771,236,715.69 |
Paid-In Capital(Or Share Stock) |
504,248,738.00 |
Capital Surplus |
4,065,496,771.47 |
Surplus Reserve |
252,124,369.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
2,534,082,099.34 |
Minority Stockholder's Interest |
69,195,088.10 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,355,951,977.81 |
Owner's Equity(Stockholder's Equity) |
7,425,147,065.91 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
8,196,383,781.60 |